HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance

Beige Zong(First Affiliated Hospital of Chongqing Medical University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Oncology Reports
May 21, 2021
Cited by 30


Related Papers